ANTX · AN2 Therapeutics, Inc. · Share Buybacks
$5.08
-0.14 (-2.68%)
At close · Nov 20
Return incl. dividend (before tax)
Market Cap
$192.75M
Shares
37.94M
Volume · Nov 20
332.71K
Avg daily vol (3M)
288.4K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-04-09 | — | $80,000,000 | — | — | 10-Q , filed 2026-05-11 |
Key facts
CIK
1880438
CUSIP
037326105
13F (30d)
94 filings
85 filers
Visit website
Investor relations